Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
ScienceDaily | March 24, 2017
A rare and aggressive form of skin cancer, MCC, is 35 times less common than melanoma, but on average, it is about three times more likely to be deadly. Until now, there were no systemic.